Featured Story | By Eric Sagonowsky Upon its FDA approval in 2018, Teva’s migraine prevention medicine Ajovy faced tough prospects as it trailed a rival into the market with a less desirable delivery method. Nearly two years later, with an approval for an autoinjector device in hand, Teva's launch is beginning to kick into gear. read more |
| |
|---|
|
Top Stories By Fraiser Kansteiner With competition to Johnson & Johnson's intravenous Darzalex mounting, the drugmaker is hustling to convert patients to its subcutaneous version of the drug, Darzalex Faspro. Now, a triumph in the clinic has armed the drugmaker with data that should convince regulators to clear Faspro in another indication—widening its edge over a Sanofi rival. read more By Amirah Al Idrus Halozyme CEO Helen Torley has always been frank about what would happen if the company’s foray into drug development failed: the two-pillar company would ditch its internal pipeline and focus solely on providing its drug delivery technology to pharma partners. Now, that transparency has turned out to be key in keeping the company alive—and profitable. read more By Fraiser Kansteiner After a troubled four years getting its oral acromegaly therapy Mycapssa across the FDA finish line, Chiasma is plotting a commercial rollout for 2020's fourth quarter. And the company has some longer-term data to tout in its bid to switch patients from their customary injections. read more |  | During this webinar, Arcturus Therapeutics & Catalent Biologics discuss how their partnership will enable and expedite scale-up to large-scale manufacturing, how it applies to the pandemic, and how it can be applied to future vaccine development. View the webinar now. |
Enrollment Showcase | Presented by: Biotility Taught by experienced professionals, Biotility’s online short courses provide the knowledge and practical skills valued by the bioscience industry. Enhance your career through coursework in one of our certificate pathways, including Document Management, Operations Management, and Quality Management. Learn more. |
| |
|---|
|
Resources Sponsored by: Thermo Fisher Scientific How to select the right dosage form for your Phase I clinical supply. Sponsored by: Thermo Fisher Scientific Quality by Design (QbD) reduces risk within drug development, while bringing therapies to market quicker. Sponsored by: Evotec Two informative webcasts will present practical and methodological approaches to preclinical drug abuse liability assessment Sponsored by: Catalent Pharmaceutical and biotech companies are spending years developing drugs or promising new biologics, all with the hopes of saving or enhancing patients’ lives. It’s a “race to the finish” in some cases, and the quicker a company can get its product to patients, the better. Sponsored by: Cardinal Health 3PL Services Identifying opportunities to simplify channel strategies and business processes for biopharma companies, their customers and patients. Sponsored by: Acorn AI by Medidata, a Dassault Systèmes company Case Study: Oncology-focused pharmaceutical company strengthens product launch by identifying hundreds of high-value physicians with Acorn AI. Sponsored by: Paysign Download the whitepaper for a solution designed to connect manufacturers, pharmacists, and patients. In this special guide, you will learn not just about the law but about the portal platform designed to change the entire process for all. Sponsored by: Catalent In a BioPharma Dive industry survey, planning and forecasting were identified as top concerns for trial sponsors. In response to this need, the CSM team at Catalent has developed a methodology for identifying, evaluating, and proactively managing the inherent risks involved in clinical trial supply chain management. Sponsored by: Phlow Corp. Interested in putting patients, people, and planet over profit in a fast-paced environment? Please Apply: VP of Integrated Supply Chain and VP of Manufacturing, Science, & Technology Sponsored by: Lonza Pharma & Biotech A novel spray-dried dispersion platform has been developed to faciliate high drug load applications Sponsored by: PRA Health Sciences Collaboration across the industry will be key to meeting the demands of the RACE Act and ensuring pediatric patients receive the care and treatments they need. Sponsored by: InterSystems Accurate, timely insights are everything. Whatever the question, the answers demand real world data you can trust. Healthy data advances reliable insights, and takes the error out of AI. Healthy data is not just useable, but invaluable. Healthy data starts with InterSystems. | 
